Show simple item record

dc.contributor.authorLacey, Simon
dc.contributor.authorMitchell, Andrew David
dc.coverage.spatialASIA AND THE PACIFIC
dc.coverage.spatialINDIA
dc.coverage.spatialCHINA
dc.coverage.spatialSINGAPORE
dc.coverage.spatialCAMBODIA
dc.coverage.spatialVIET NAM
dc.coverage.spatialBANGLADESH
dc.coverage.spatialVANUATU
dc.coverage.spatialAUSTRALIA
dc.creatorUN.ESCAP
dc.creatorAsia-Pacific Research and Training Network on Trade (ARTNeT)
dc.date.accessioned2022-11-14T02:11:30Z
dc.date.available2022-11-14T02:11:30Z
dc.date.issued2022-11
dc.identifier.urihttps://hdl.handle.net/20.500.12870/5084
dc.description.abstract<p>The global health crisis that came to be known as the COVID-19 pandemic and started to sweep across the world in early 2020 revealed many vulnerabilities in the economic, social, and political fabric underpinning what much of the world had come to accept as normal. In ways that we are still grappling to understand, the pandemic and the many disruptions it brought about have ushered in significant changes to the way we work, consume, spend our leisure time, and even our relationships to government. In many ways, the pandemic has wrought a significant realignment between citizens and governments, both in terms of the expectations the former have of the latter and the powers the latter claims and exerts over the former. This paper explores the ways in which medicines (of which vaccines are a subset) are regulated today and what goals governments generally pursue in this policy area. It then turns to an examination of international regulatory cooperation in medicines before examining the unprecedented levels of international cooperation seen in response to the COVID-19 pandemic between not only governments but also the private sector and non-governmental organizations. The paper seeks to elucidate the regulatory cooperation in the area of vaccines that took place during the COVID-19 pandemic in the Asia-Pacific and concludes by discussing the present outlook while also setting out some policy recommendations for governments going forward.</p>
dc.format.extentix, 73 p.
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherARTNeT
dc.relation.ispartofseriesARTNeT Working Paper
dc.rightsThis publication may be reproduced in whole or in part for educational or non-profit purposes without special permission from the copyright holder, provided that the source is acknowledged. The ESCAP Publications Office would appreciate receiving a copy of any publication that uses this publication as a source.
dc.rightsUse may not be made of this publication for resale or any other commercial purpose whatsoever without prior permission. Applications for such permission, with a statement of the purpose and extent of reproduction, should be addressed to the Secretary of the Publications Board, United Nations, New York.
dc.subjectRegulatory cooperation
dc.titleRegulatory cooperation in vaccines in the Asia-Pacific region : special series on trade and health
dc.typeText
dc.rights.holderUnited Nations
dc.subject.unbistVACCINES
dc.subject.unbistCOVID-19
dc.subject.unbistREGIONAL COOPERATION
dc.subject.unbistHEALTH POLICY
dc.subject.unbistMEDICINE
dc.subject.unbistCASE STUDIES
escap.publisherPlaceBangkok
escap.doctypeWorking paper
escap.programmeOfWorkTrade, Investment & Innovation
escap.areasOfWorkTrade Facilitation & Digital Trade
escap.areasOfWorkTrade Policy & Integration
escap.link.internalLinkhttps://www.unescap.org/kp/2022/regulatory-cooperation-vaccines-asia-pacific-region
escap.subregionEast and North-East Asia
escap.subregionPacific
escap.subregionSouth and South-West Asia
escap.subregionSouth-East Asia
escap.contactPhone+66 2 288-1234
escap.contactEmail[email protected]
escap.contactUnitTrade, Investment and Innovation Division
escap.ispartofseriesnoARTNet Working Paper;No. 219
dc.date.escap2022-11-01
dc.relation.ispartofseriesnoNo. 219


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record